BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  AnorMED Announces 73 Percent Of Cancer Patients Who Failed Prior Chemotherapy Mobilizations Succeed In Collecting Enough Stem Cells For Transplant In MOZOBIL(TM) Compassionate Use Program

  December 12, 2005

   · 

  11 min read
• Drug Development

  Immunomedics, Inc. Reports Humanized Anti-CD20 Antibody Appears Safe And Active In Non-Hodgkin’s Lymphoma

  December 12, 2005

   · 

  4 min read
• Business

  PAREXEL International Appoints Todd A. Joron As Corporate Vice President And General Manager Of Perceptive Informatics

  December 12, 2005

   · 

  5 min read
• Business

  Novartis Farmaceutica Powers Training Program With Saba

  December 12, 2005

   · 

  3 min read
• Drug Development

  Cell Genesys, Inc. Reports Positive Results From Phase 2 Trial Of GVAX(R) Vaccine For Leukemia In Chronic Myelogenous Leukemia

  December 12, 2005

   · 

  5 min read
• Drug Development

  Allos Therapeutics, Inc. Release: PDX Shows Promising Activity In Patients With Resistant T-Cell Lymphomas

  December 12, 2005

   · 

  7 min read
• Policy

  Merck & Co., Inc. Release: Hung Jury In First Federal VIOXX(R) Product Liability Trial

  December 12, 2005

   · 

  1 min read
• Drug Development

  Unither Pharmaceuticals, Inc. Completes Enrollment In First Of Two Phase III Trials Of OvaRex In Advanced Ovarian Cancer

  December 12, 2005

   · 

  3 min read
• Biotech Beach

  Nanogen, Inc. Releases Two Products For The Detection Of Respiratory Viral Pathogens

  December 12, 2005

   · 

  4 min read
• Drug Development

  Celgene Release: Revlimid(R) Improves Overall Survival And Delays Time To Disease Progression In Previously Treated Multiple Myeloma Patients

  December 12, 2005

   · 

  6 min read